🔗 Share this article

The top legal official in Texas Paxton is suing the producers of Tylenol, alleging the corporations withheld safety concerns that the pain reliever presented to pediatric brain development.

The lawsuit comes a month after Donald Trump advocated an unverified association between consuming Tylenol - referred to as acetaminophen - throughout gestation and autism spectrum disorder in offspring.

The attorney general is filing suit against J&J, which formerly manufactured the drug, the only pain reliever suggested for expectant mothers, and the current manufacturer, which now manufacturers it.

In a declaration, he claimed they "betrayed America by gaining financially from pain and promoting medication ignoring the dangers."

The manufacturer states there is insufficient reliable data connecting acetaminophen to autism.

"These corporations misled for generations, intentionally threatening numerous people to line their pockets," the attorney general, from the Republican party, declared.

The company commented that it was "very worried by the dissemination of inaccurate information on the security of paracetamol and the possible consequences that could have on the welfare of women and children in America."

On its online platform, Kenvue also stated it had "continuously evaluated the pertinent research and there is lacking reliable evidence that indicates a proven link between using paracetamol and autism."

Associations representing medical professionals and medical practitioners concur.

ACOG has declared acetaminophen - the key substance in Tylenol - is one of the few options for women during pregnancy to manage pain and fever, which can pose major wellness concerns if not addressed.

"In multiple decades of studies on the utilization of acetaminophen in pregnancy, no reliable research has conclusively proven that the usage of paracetamol in any trimester of pregnancy causes brain development issues in offspring," the association commented.

This legal action cites latest statements from the former administration in arguing the medication is reportedly hazardous.

Recently, Trump caused concern from public health officials when he told expectant mothers to "resist strongly" not to use Tylenol when ill.

The US Food and Drug Administration then issued a notice that physicians should consider limiting the usage of acetaminophen, while also mentioning that "a proven link" between the drug and autism spectrum disorder in young ones has remains unverified.

The Health Department head Kennedy, who supervises the Food and Drug Administration, had vowed in spring to undertake "comprehensive study program" that would determine the source of autism in a matter of months.

But specialists advised that finding a sole reason of autism - thought by researchers to be the outcome of a complicated interplay of inherited and surrounding conditions - would prove challenging.

Autism spectrum disorder is a type of permanent neurological difference and condition that impacts how people experience and relate to the world, and is identified using physician assessments.

In his legal document, the attorney general - a Trump ally who is seeking US Senate - claims the manufacturer and Johnson & Johnson "intentionally overlooked and sought to suppress the science" around acetaminophen and autism spectrum disorder.

This legal action aims to force the firms "eliminate any promotional materials" that asserts Tylenol is reliable for expectant mothers.

This legal action parallels the concerns of a collection of parents of children with autism spectrum disorder and ADHD who filed suit against the manufacturers of acetaminophen in recently.

The court dismissed the case, stating research from the parents' expert witnesses was inconclusive.